News
However, trust gaps among clinicians and patients are threatening to slow the adoption and impact of AI. Among HCPs, ...
Join the 4th Process Development for Cell Therapies Summit to hear from 24+ industry leaders from biopharma and service ...
MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid ...
AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis ...
France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in ...
US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has made his first testimonies in front of Congress since he ...
Since December 2022, and COP decision 15/9, members of the Convention on Biological Diversity (the CBD) have been negotiating ...
New research reveals some significant imbalances between healthcare professionals' (HCP) demand and industry's provision of medical information, based on content types, channels and format.
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...
pharmaphorum is your source for news and analysis to stay on top of happenings in the world of pharma. Founded in 2009, pharmaphorum’s mission has always been to educate, inform, engage, and ...
2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape relations. Regulation and deregulation may alter processes. And any ...
Market research can identify ways to lower costs and improve revenues, if it is approached methodically. Here are some tips for success. The slow-down in growth in the pharma industry over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results